Skip to main content

2019 Grant Recipients

Project

Funding

Chief Investigator

The effect of enteral glycine on plasma glycine and muscle histopathology, structure and function in the critically ill. (No. 1914) Dr Rene Koopman
FLudrocortisone pharmacokinetics and pharmacodynamics in septic shock. A phase II open label randomised controlled clinical trial of different dosing regimens. (No. 1934) Dr James Walsham
Linking ANZICS CORE and the National Death Index: Perpetual, national, long term survival data to benchmark quality. (No. 1922) Adjunct Clinical Prof. David Pilcher
ImmuneCAP: Tissue Resident Memory T-Cell response in severe Community Acquired Pneumonia. (No. 1901) Dr Christopher Andersen
MUSCLE health in response to augmented PROtein delivery in critically ill patients (The Muscle-Pro Study) (No. 1905) Dr Lee-anne Chapple
Biofluids induced lung injury in acute respiratory distress syndrome (No. 1916) A/Prof Gianluigi Li Bassi
PAIN in Survivors of Intensive Care Units (The PAIN-ICU Study): A Prospective, Multi-centre Observational Cohort Study to Determine the Incidence, risk Factors and Impact of Chronic Pain in Critically Ill Adult Patients Discharged from ICU. (No. 1918) Dr Benjamin Moran

 

ProjectChief Investigatorprofile
AUGMENTED Protein in critical illness: TARGET PROTEIN PILOT Trial
Lee-anne Chapple
Australian and New Zealand Intensive Care Society Patient Reported Outcomes and Experience Measures (PROEMs) Program
Paul Secombe
Sepsis resuscitation and Acute Kidney Injury: a prospective nested cohort study of AKI in the ARISE FLUIDS Randomised Controlled Trial
Melissa Ankravs
Promoting safe, high quality care for every child: Harnessing binational knowledge and expertise to develop quality indicators for paediatric critical care
Jessica Schults
Iron and erythropoietin To Heal and Recover after Intensive Care: ITHRIVE Pilot Randomised Clinical Trial
Sarah van der Laan
more...
ProjectChief Investigator
Primary Health Care Use in ICU Survivors: A Data Linkage Study
Kelly Thompson